Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000801349 | SCV000941123 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2018-08-29 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 12-16 of the MSH2 gene. The 5' boundary is likely confined to intron 11. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. A similar deletion of exons 12-16 has been observed in an individual with clinical features of Lynch syndrome (PMID: 15342696). Sub-genic deletions of exons 14-16 have been determined to be pathogenic (PMID: 25430799, Invitae). Therefore, deletions that fully encompass that region are also expected to be pathogenic. For these reasons, this variant has been classified as Pathogenic. |